ArticleBrain communications2025
Examining the genetic relationship between Alzheimer's disease, schizophrenia and their shared risk factors using genomic structural equation modelling.
Article in Brain communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The Inflammatory Nexus: Unraveling Shared Pathways and Promising Treatments in Alzheimer's Disease and Schizophrenia.International journal of molecular sciences · 2025Review
- Schizophrenia and dementia across the lifespan: epidemiological links, cognitive trajectories, and the pathophysiological interplay.Frontiers in neurologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Epidemiological studies have demonstrated an association between dementia and schizophrenia. There is a significant symptom overlap between the two disorders-psychosis is seen in 50% of patients with Alzheimer's disease and cognitive impairment is a key feature of schizophrenia. Whether these overlapping clinical presentations reflect shared aetiology is unclear. Therefore, we aimed to model the genetic correlation between Alzheimer's disease, schizophrenia and their shared risk factors using genomic structural equation modelling to identify potentially overlapping biological pathways between these traits. We measured genetic correlation between Alzheimer's disease, schizophrenia and 13 shared risk factors, including body fat percentage, less education, alcohol intake, insomnia, loneliness, less social/leisure activity, major depression, mean arterial pressure, smoking, socioeconomic deprivation, low-density lipoprotein cholesterol, eye problems and type 2 diabetes mellitus. Schizophrenia and Alzheimer's disease were not significantly genetically correlated but were both significantly associated with loneliness. Colocalization suggested that the association between loneliness and Alzheimer's disease was predominantly driven by a shared causal variant on Chromosome 11. Factor analysis of shared risk factors produced four latent factors representing clusters of shared genetics between socioeconomic traits, psychiatric traits, cardiometabolic traits and smoking-related traits. Both Alzheimer's disease and schizophrenia were significantly associated with the socioeconomic latent factor. Although there is little direct genetic overlap between schizophrenia and Alzheimer's disease, loneliness may play an important role in the association between these two disorders. In addition, the shared genetics between socioeconomic traits may affect susceptibility to both Alzheimer's disease and schizophrenia to a greater extent than trait-specific pathways.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.